Characterization of a novel third member of the human cytomegalovirus glycoprotein H-glycoprotein L complex

Journal of Virology

Volumn 71, Issue 7, 1997, Pages 5391-5398

  Huber, Mary T ^a   Compton, Teresa ^a,b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN;

ANIMAL CELL; ARTICLE; COMPLEX FORMATION; CYTOMEGALOVIRUS; DISULFIDE BOND; GENETIC RECOMBINATION; IMMUNOPRECIPITATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RECEPTOR GENE; VIRION; VIRUS CELL INTERACTION; VIRUS NEUTRALIZATION;

EID: 0030923359     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.7.5391-5398.1997     Document Type: Article

References (36)

1. Bogner, E., M. Reschke, B. Reis, E. Reis, W. Britt, and K. Radsak. 1992. Recognition of compartmentalized intracellular analogs of glycoprotein H of human cytomegalovirus. Arch. Virol. 126:67-80.
2. Britt, W. J., and D. Auger. 1985. Identification of a 65,000 dalton virion envelope protein of human cytomegalovirus. Virus Res. 4:31-36.
3. Britt, W. J., L. Vugler, E. J. Butfiloski, and E. B. Stephens. 1990. Cell surface expression of human cytomegalovirus (HCMV) gp55-116 (gB): use of HCMV-recombinant vaccinia virus-infected cells in analysis of the human neutralizing antibody response. J. Virol. 64:1079-1085.
4. Carlson, C., W. J. Britt, and T. Compton. Expression, purification and characterization of a soluble form of human cytomegalovirus glycoprotein B. Submitted for publication.
5. Chee, M. S., A. T. Bankier, S. Beck, R. Bohni, C. M. Brown, R. Cerny, T. Horsnell, C. A. Hutchison III, T. Kouzarides, J. A. Martignetti, E. Preddie, S. C. Satchwell, P. Tomlinson, K. M. Weston, and B. G. Barrell. 1990. Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169. Curr. Top. Microbiol. Immunol. 154:125-169.
6. Compton, T. 1993. An immortalized human fibroblast cell line is permissive for human cytomegalovirus infection. J. Virol. 67:3644-3648.
7. Cranage, M. P., G. L. Smith, S. E. Bell, H. Hart, C. Brown, A. T. Bankier, P. Tomlinson, B. G. Barrell, and T. C. Minson. 1988. Identification and expression of a human cytomegalovirus glycoprotein with homology to the Epstein-Barr virus BXLF2 product, varicella-zoster virus gpIII, and herpes simplex virus type 1 glycoprotein H. J. Virol. 62:1416-1422.
8. Desai, P. J., P. A. Schaffer, and A. C. Minson. 1988. Excretion of noninfectious virus particles lacking glycoprotein H by a temperature-sensitive mutant of herpes simplex virus type 1: evidence that gH is essential for virion infectivity. J. Gen. Virol. 69:1147-1156.
9. Fleckenstein, B., I. Muller, and J. Collins. 1982. Cloning of the complete human cytomegalovirus genome in cosmids. Gene 18:39-46.
10. Forrester, A., H. Farrell, G. Wilkinson, J. Kaye, N. Davis-Poynter, and T. Minson. 1992. Construction and properties of a mutant of herpes simplex virus type 1 with glycoprotein H coding sequences deleted. J. Virol. 66:341-348.
11. Fuerst, T. R., E. G. Niles, F. W. Studies, and B. Moss. 1986. Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc. Natl. Acad. Sci. USA 83:8122-8126.
12. Fuller, A. O., and W.-C. Lee. 1992. Herpes simplex virus type 1 entry through a cascade of virus-cell interactions requires different roles of gD and gH in penetration. J. Virol. 66:5002-5012.
13. Fuller, A. O., R. E. Santos, and P. G. Spear. 1989. Neutralizing antibodies specific for glycoprotein H of herpes simplex virus permit viral attachment to cell bul prevent penetration. J. Virol. 63:3435-3443.
14. Gretch, D. R., B. Kari, L. Rasmussen, R. C. Gehrz, and M. F. Stinski. 1988. Identification and characterization of three distinct families of glycoprotein complexes in the envelopes of human cytomegalovirus. J. Virol. 62:875-881.
15. Johnson, E., W. Henzel, and A. Deisseroth. 1992. An isoform of protein disulfide isomerase isolated from chronic myelogenous leukemia cells alters complex formation between nuclear proteins and regulatory regions of interferon-inducible genes. J. Biol. Chem. 267:14412-14417.
16. Kaetzel, C. S., C. K. Rao, and M. E. Lamm. 1987. Protein disulphide isomerase from human placenta and rat liver. Purification and immunological characterization with monoclonal antibodies. Biochem. J. 241:39-47.
17. Kaye, J. F., G. U. A. Compels, and A. C. Minson. 1992. Glycoprotein H of human cytomegalovirus (HCMV) forms a stable complex with the HCMV UL115 gene product. J. Gen. Virol. 73:2693-2698.
18. Keay, S., and B. Baldwin. 1991. Anti-idiotype antibodies that mimic gp86 of human cytomegalovirus inhibit viral fusion but not attachment. J. Virol. 65:5124-5128.
19. Keay, S., T. C. Merigan, and L. Rasmussen. 1989. Identification of cell surface receptors for the 86-kilodalton glycoprotein of human cytomegalovirus. Proc. Natl. Acad. Sci. USA 86:10100-10103.
20. Li, Q., S. M. Turk, and L. M. Hutt-Fletcher. 1995. The Epstein-Barr virus (EBV) BZLF2 gene product associates with the gH and gL homologs of EBV and carries an epitope critical to infection of B cells but not of epithelial cells. J. Virol. 69:3987-3994.
21. Miller, N., and L. M. Hutt-Fletcher. 1988. A monoclonal antibody to glycoprotein gp85 inhibits fusion but not attachment to Epstein-Barr virus. J. Virol. 62:2366-2372.
22. Nowlin, D. M., N. R. Cooper, and T. Compton. 1991. Expression of a human cytomegalovirus receptor correlates with infectibility of cells. J. Virol. 65: 3114-3121.
23. Pachl, C., W. S. Probert, K. M. Hermsen, F. Masiarz, L. Rasmussen, T. C. Merigan, and R. R. Spaete. 1989. The human cytomegalovirus strain Towne glycoprotein H gene encodes glycoprotein p86. Virology 169:418-426.
24. Peeters, B., N. de Wind, R. Broer, A. Gielkens, and R. Moormann. 1992. Glycoprotein H of pseudorabies virus is essential for entry and cell-to-cell spread of the virus. J. Virol. 66:3888-3892.
25. Rasmussen, L., R. Nelson, D. Kelsall, and T. Merigan. 1984. Murine monoclonal antibody to a single protein neutralizes the infectivity of human cytomegalovirus. Proc. Natl. Acad. Sci. USA 81:876-880.
26. Rodriguez, J. E., T. Moninger, and C. Grose. 1993. Entry and egress of varicella virus blocked by same anti-gH monoclonal antibody. Virology 196: : 840-844.
27. Roop, C., L. Hutchinson, and D. C. Johnson. 1993. A mutant herpes simplex virus type 1 unable to express glycoprotein L cannot enter cells, and its particles lack glycoprotein H. J. Virol. 67:2285-2297.
28. Schmidt, T. G. M., and A. Skerra. 1993. The random peptide library-assisted engineering of a C-terminal affinity peptide, useful for the detection and purification of a functional Ig Fv fragment. Protein Eng. 6:109-122.
29. Spaete, R. R., K. Perot, P. I. Scott, J. A. Nelson, M. F. Stinski, and C. Pachl. 1993. Coexpression of truncated human cytomegalovirus gH with the UL115 gene product or the truncated human fibroblast growth factor receptor results in the transport of gH to the cell surface. Virology 193:853-861.
30. Stewart, L., M. Hirst, M. L. Ferber, A. Merryweather, P. J. Cayley, and R. Possee. 1991. Construction of an improved baculovirus insecticide containing an insect-specific toxin gene. Nature 352:85-88.
31. Stinski, M. F. 1976. Human cytomegalovirus: glycoproteins associated with virions and dense bodies. J. Virol. 19:594-609.
32. Taylor, H. P., and N. R. Cooper. 1989. Human cytomegalovirus binding to fibroblasts is receptor mediated. J. Virol. 63:3991-3998.
33. Thomsen, D. R., L. E. Post, and A. P. Elhammer. 1990. Structure of Oglycosidically linked oligosaccharides synthesized by the insect cell line Sf9. J. Cell. Biochem. 43:67-79.
34. Urban, M., W. Britt, and M. Mach. 1992. The dominant linear neutralizing antibody-binding site of glycoprotein gp86 of human cytomegalovirus is strain specific. J. Virol. 66:1303-1311.
35. Vuori, K., T. Pihlajaniemi, M. Marttila, and K. I. Kivirikko. 1992. Characterization of the human prolyl 4-hydroxylase tetramer and its multifunctional protein disulfide-isomerase subunit synthesized in a baculovirus expression system. Proc. Natl. Acad. Sci. USA 89:7467-7470.
36. Yamashita, Y., K. Shimokata, S. Mizuno, T. Daikoku, T. Tsurumi, and Y. Nishiyama. 1996. Calnexin acts as a molecular chaperone during the folding of glycoprotein B of human cytomegalovirus. J. Virol. 70:2237-2246.